CHINA MEDICAL TECHNOLOGIES, INC SPN ADR
CMED
CMED was delisted on the 6th of February, 2012.
1 hedge funds and large institutions have $128 invested in CHINA MEDICAL TECHNOLOGIES, INC SPN ADR in 2023 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
50% less capital invested
Capital invested by funds: $256 → $128 (-$128)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UCB
United Community Bank
Greenville,
South Carolina
|
-$128 |
CMED Hedge Fund Activity: Q3 2023 in Review
1 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in CHINA MEDICAL TECHNOLOGIES, INC SPN ADR (CMED) for Q3 2023, worth a combined $128 — down 50% from $256 a quarter earlier.
Fund positioning in CMED was balanced in Q3 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was United Community Bank, cutting an estimated $128.
- 1 institutional investor held CHINA MEDICAL TECHNOLOGIES, INC SPN ADR (CMED) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $128 of CHINA MEDICAL TECHNOLOGIES, INC SPN ADR stock for Q3 2023, down 50% quarter-over-quarter.
- 0 funds opened new CHINA MEDICAL TECHNOLOGIES, INC SPN ADR positions in Q3 2023 and 0 closed out.
- The largest CHINA MEDICAL TECHNOLOGIES, INC SPN ADR seller in Q3 2023 was United Community Bank, an estimated $128 sold.
Based on aggregated 13F filings for Q3 2023.